The anti-cancer treatment Yescarta was recently approved by the U.S. Food and Drug Administration as a treatment for lymphoma. It's part of a new approach to combatting blood cancers by re-engineering the immune system.
Karen Weintraub from member station WBUR reports.
This segment aired on November 23, 2017.
- For Some, Cutting-Edge 'CAR-T' Treatment Unleashes 'Pac-Man' Cells Against Blood Cancer
- FDA Approves First Gene Therapy For Leukemia
- New Discoveries In Pancreatic Cancer Research Offer Hope